Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunogenicity of a psoralen-inactivated dengue virus type 1 vaccine candidate in mice.

Literature DB >> 20007362

Immunogenicity of a psoralen-inactivated dengue virus type 1 vaccine candidate in mice.

Ryan C Maves¹, Roger M Castillo Oré, Kevin R Porter, Tadeusz J Kochel.

Abstract

We evaluated a novel psoralen-inactivated dengue virus type 1 (DENV-1) vaccine candidate in Mus musculus mice. Mice received intradermal alum or 5 to 10 ng of psoralen-inactivated virus. Anti-DENV-1 neutralizing antibody was detectable in 10/11 mice receiving a 10-ng dose at 90 days. Psoralen-inactivated DENV-1 is immunogenic in mice.

Entities: Species

Mesh：

Substances：

Year: 2009 PMID： 20007362 PMCID： PMC2815535 DOI： 10.1128/CVI.00353-09

Source DB: PubMed Journal: Clin Vaccine Immunol ISSN： 1556-679X

11 in total

1. Photochemical inactivation of DNA and RNA viruses by psoralen derivatives.

Authors: C V Hanson; J L Riggs; E H Lennette
Journal: J Gen Virol Date: 1978-08 Impact factor: 3.891

2. An overview of the inactivation of FMDV and the implications when residual virus is present in vaccines.

Authors: F Brown
Journal: Dev Biol Stand Date: 1991

Review 3. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections.

Authors: John D Roback; Maureen Conlan; W Lawrence Drew; Per Ljungman; W Garrett Nichols; Jutta K Preiksaitis
Journal: Transfus Med Rev Date: 2006-01

4. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization.

Authors: D M Morens; S B Halstead; P M Repik; R Putvatana; N Raybourne
Journal: J Clin Microbiol Date: 1985-08 Impact factor: 5.948

5. Psoralen photochemistry and nucleic acid structure.

Authors: J E Hearst
Journal: J Invest Dermatol Date: 1981-07 Impact factor: 8.551

6. A potential molecular mechanism for hypersensitivity caused by formalin-inactivated vaccines.

Authors: Amin Moghaddam; Wieslawa Olszewska; Belinda Wang; John S Tregoning; Rebecca Helson; Quentin J Sattentau; Peter J M Openshaw
Journal: Nat Med Date: 2006-07-23 Impact factor: 53.440

7. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light.

Authors: L Lin; D N Cook; G P Wiesehahn; R Alfonso; B Behrman; G D Cimino; L Corten; P B Damonte; R Dikeman; K Dupuis; Y M Fang; C V Hanson; J E Hearst; C Y Lin; H F Londe; K Metchette; A T Nerio; J T Pu; A A Reames; M Rheinschmidt; J Tessman; S T Isaacs; S Wollowitz; L Corash
Journal: Transfusion Date: 1997-04 Impact factor: 3.157

8. Psoralen preparation of antigenically intact noninfectious rotavirus particles.

Authors: W S Groene; R D Shaw
Journal: J Virol Methods Date: 1992-07 Impact factor: 2.014

9. Quantification of viral inactivation by photochemical treatment with amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplification.

Authors: Jean-Pierre Allain; Jocelyn Hsu; Manisha Pranmeth; Deborah Hanson; Adonis Stassinopoulos; Lucia Fischetti; Laurence Corash; Lily Lin
Journal: J Infect Dis Date: 2006-11-08 Impact factor: 5.226

10. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function.

Authors: Yasmin Singh; Lynette S Sawyer; Linda S Pinkoski; Kent W Dupuis; Jocelyn C Hsu; Lily Lin; Laurence Corash
Journal: Transfusion Date: 2006-07 Impact factor: 3.157

6 in total

1. Dengue virus photo-inactivated in presence of 1,5-iodonaphthylazide (INA) or AMT, a psoralen compound (4'-aminomethyl-trioxsalen) is highly immunogenic in mice.

Authors: Kanakatte Raviprakash; Peifang Sun; Yossef Raviv; Thomas Luke; Nicholas Martin; Tadeusz Kochel
Journal: Hum Vaccin Immunother Date: 2013-07-08 Impact factor: 3.452

2. Immunogenic Properties of a BCG Adjuvanted Chitosan Nanoparticle-Based Dengue Vaccine in Human Dendritic Cells.

Authors: Taweewun Hunsawong; Panya Sunintaboon; Saradee Warit; Butsaya Thaisomboonsuk; Richard G Jarman; In-Kyu Yoon; Sukathida Ubol; Stefan Fernandez
Journal: PLoS Negl Trop Dis Date: 2015-09-22

3. Psoralen inhibits hepatitis B viral replication by down-regulating the host transcriptional machinery of viral promoters.

Authors: Xinna Ma; Heng Li; Ying Gong; Feifei Liu; Xiankun Tong; Fenghua Zhu; Xiaoqian Yang; Li Yang; Jianping Zuo
Journal: Virol Sin Date: 2022-01-25 Impact factor: 6.947